Vortioxetine -SIL NDSRI
References
FAQ's
References
- Ruhland, Thomas; Smith, Garrick Paul; Bang-Andersen, Benny; Pueschl, Ask; Moltzen, Ejner Knud; Andersen, Kim, Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors, H. Lundbeck A/S, Denmark, WO2003029232A1, April 10, 2003
- Atila Karaca, Sakine; Rashidova, Nurana; Ugur, Alper; Yeniceli Ugur, Duygu, Development of a simple HPLC method for the quantitation of vortioxetine in pharmaceuticals using DoE approach, Chemical Papers, Volume: 74, Issue: 5, Pages: 1541-1549, 2020
Frequently Asked Questions
Can Vortioxetine impurities be customized?
Some providers specialize in customizing Vortioxetine impurities to meet client specifications.
Can Vortioxetine impurities pose risks to patients?
Yes, certain impurities in Vortioxetine can potentially pose risks to patients and is essential to detect them.
How are Vortioxetine impurities identified and characterized?
Vortioxetine impurities are identified and characterized using advanced analytical techniques such as mass spectrometry (MS).
How should Vortioxetine impurities be stored in terms of temperature?
The recommendation is to store Vortioxetine impurities at room temperature, within 2-8 °C.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.